Cargando…
In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases
Onchocerciasis is a parasitic disease with high socio-economic burden particularly in sub-Saharan Africa. The elimination plan for this disease has faced numerous challenges. A multi-epitope prophylactic/therapeutic vaccine targeting the infective L3 and microfilaria stages of the parasite’s life cy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416346/ https://www.ncbi.nlm.nih.gov/pubmed/30867498 http://dx.doi.org/10.1038/s41598-019-40833-x |
_version_ | 1783403339499700224 |
---|---|
author | Shey, Robert Adamu Ghogomu, Stephen Mbigha Esoh, Kevin Kum Nebangwa, Neba Derrick Shintouo, Cabirou Mounchili Nongley, Nkemngo Francis Asa, Bertha Fru Ngale, Ferdinand Njume Vanhamme, Luc Souopgui, Jacob |
author_facet | Shey, Robert Adamu Ghogomu, Stephen Mbigha Esoh, Kevin Kum Nebangwa, Neba Derrick Shintouo, Cabirou Mounchili Nongley, Nkemngo Francis Asa, Bertha Fru Ngale, Ferdinand Njume Vanhamme, Luc Souopgui, Jacob |
author_sort | Shey, Robert Adamu |
collection | PubMed |
description | Onchocerciasis is a parasitic disease with high socio-economic burden particularly in sub-Saharan Africa. The elimination plan for this disease has faced numerous challenges. A multi-epitope prophylactic/therapeutic vaccine targeting the infective L3 and microfilaria stages of the parasite’s life cycle would be invaluable to achieve the current elimination goal. There are several observations that make the possibility of developing a vaccine against this disease likely. For example, despite being exposed to high transmission rates of infection, 1 to 5% of people have no clinical manifestations of the disease and are thus considered as putatively immune individuals. An immuno-informatics approach was applied to design a filarial multi-epitope subunit vaccine peptide consisting of linear B-cell and T-cell epitopes of proteins reported to be potential novel vaccine candidates. Conservation of the selected proteins and predicted epitopes in other parasitic nematode species suggests that the generated chimera could be helpful for cross-protection. The 3D structure was predicted, refined, and validated using bioinformatics tools. Protein-protein docking of the chimeric vaccine peptide with the TLR4 protein predicted efficient binding. Immune simulation predicted significantly high levels of IgG(1), T-helper, T-cytotoxic cells, INF-γ, and IL-2. Overall, the constructed recombinant putative peptide demonstrated antigenicity superior to current vaccine candidates. |
format | Online Article Text |
id | pubmed-6416346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64163462019-03-15 In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases Shey, Robert Adamu Ghogomu, Stephen Mbigha Esoh, Kevin Kum Nebangwa, Neba Derrick Shintouo, Cabirou Mounchili Nongley, Nkemngo Francis Asa, Bertha Fru Ngale, Ferdinand Njume Vanhamme, Luc Souopgui, Jacob Sci Rep Article Onchocerciasis is a parasitic disease with high socio-economic burden particularly in sub-Saharan Africa. The elimination plan for this disease has faced numerous challenges. A multi-epitope prophylactic/therapeutic vaccine targeting the infective L3 and microfilaria stages of the parasite’s life cycle would be invaluable to achieve the current elimination goal. There are several observations that make the possibility of developing a vaccine against this disease likely. For example, despite being exposed to high transmission rates of infection, 1 to 5% of people have no clinical manifestations of the disease and are thus considered as putatively immune individuals. An immuno-informatics approach was applied to design a filarial multi-epitope subunit vaccine peptide consisting of linear B-cell and T-cell epitopes of proteins reported to be potential novel vaccine candidates. Conservation of the selected proteins and predicted epitopes in other parasitic nematode species suggests that the generated chimera could be helpful for cross-protection. The 3D structure was predicted, refined, and validated using bioinformatics tools. Protein-protein docking of the chimeric vaccine peptide with the TLR4 protein predicted efficient binding. Immune simulation predicted significantly high levels of IgG(1), T-helper, T-cytotoxic cells, INF-γ, and IL-2. Overall, the constructed recombinant putative peptide demonstrated antigenicity superior to current vaccine candidates. Nature Publishing Group UK 2019-03-13 /pmc/articles/PMC6416346/ /pubmed/30867498 http://dx.doi.org/10.1038/s41598-019-40833-x Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Shey, Robert Adamu Ghogomu, Stephen Mbigha Esoh, Kevin Kum Nebangwa, Neba Derrick Shintouo, Cabirou Mounchili Nongley, Nkemngo Francis Asa, Bertha Fru Ngale, Ferdinand Njume Vanhamme, Luc Souopgui, Jacob In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
title | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
title_full | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
title_fullStr | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
title_full_unstemmed | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
title_short | In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
title_sort | in-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416346/ https://www.ncbi.nlm.nih.gov/pubmed/30867498 http://dx.doi.org/10.1038/s41598-019-40833-x |
work_keys_str_mv | AT sheyrobertadamu insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT ghogomustephenmbigha insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT esohkevinkum insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT nebangwanebaderrick insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT shintouocabiroumounchili insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT nongleynkemngofrancis insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT asaberthafru insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT ngaleferdinandnjume insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT vanhammeluc insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases AT souopguijacob insilicodesignofamultiepitopevaccinecandidateagainstonchocerciasisandrelatedfilarialdiseases |